| Literature DB >> 26193383 |
Fiorella Gurrieri1, Maria Luigia Cavaliere2, Anita Wischmeijer3, Corrado Mammì4, Giovanni Neri1, Maria Antonietta Pisanti2, Giulia Rodella5, Carmelo Laganà4, Manuela Priolo6.
Abstract
The Nuclear Factor I-X (NFIX) is a member of the nuclear factor I (NFI) protein family and is deleted or mutated in a subset of patients with a peculiar overgrowth condition resembling Sotos Syndrome as well as in patients with Marshall-Smith syndrome. We identified three additional patients with this phenotype each carrying a different new mutation affecting the DNA-binding/dimerization domain of the NFIX protein. The present report further adds weight to the hypothesis that mutations in DNA-binding/dimerization domain are likely to cause haploinsufficiency of the NFIX protein and confirms that NFIX is the second gene that should be tested in individuals with overgrowth conditions resembling Sotos syndrome, previously tested negative for NSD1 mutations. We then propose to consider this overgrowth syndrome (namely Malan syndrome) and Marshall-Smith syndrome NFIX-related diseases.Entities:
Keywords: DNA-Binding/dimerization domain; MH1 domain; NFIX; Overgrowth syndrome
Mesh:
Substances:
Year: 2015 PMID: 26193383 DOI: 10.1016/j.ejmg.2015.06.009
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708